Evidence map›Paper›PMID 37111039›Full record

ArticleNutrients2023

Correlation of Plasma 25(OH)D

Wajude Alabdullatif, Ahmad Almnaizel, Ali Alhijji, Aldanah Alshathri, Ahmed Albarrag, Iman Bindayel

Open access · goldAbstract read
In one paragraph

Article in Nutrients, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
1.3field-weighted citation impact, top 21% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 5 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 1 institution in 1 country.

Wajude AlabdullatifDepartment of Community Health Sciences, College of Applied Medical Sciences, King Saud University, Riyadh 11433, Saudi Arabia.ORCID 0000-0003-4143-8263
Ahmad AlmnaizelPrince Naif for Health Research Center, King Saud University, Riyadh 11472, Saudi Arabia.
Ali AlhijjiDivision of Infectious Diseases, Department of Internal Medicine, College of Medicine, King Saud University, Riyadh 11461, Saudi Arabia.ORCID 0000-0003-2074-8916
Aldanah AlshathriDepartment of Community Health Sciences, College of Applied Medical Sciences, King Saud University, Riyadh 11433, Saudi Arabia.ORCID 0000-0002-3433-715X
Ahmed AlbarragDepartment of Pathology, College of Medicine, King Saud University, Riyadh 11461, Saudi Arabia.
Iman BindayelDepartment of Community Health Sciences, College of Applied Medical Sciences, King Saud University, Riyadh 11433, Saudi Arabia.ORCID 0000-0001-5452-115X
King Saud University · SA

Funding

King Saud University RSP2022R428
6 · The paper itself

Abstract

backgroundThe Coronavirus Disease-19 (COVID-19) caused by the Severe Acute Respiratory Syndrome Coronavirus-2 (SARS-CoV-2) has been declared a worldwide pandemic. The severity of COVID-19 varies greatly across infected individuals. Possible factors may include plasma levels of 25(OH)D and vitamin D binding protein (DBP), as both are involved in the host immune response. Other possible nutrition-related factors include malnutrition and/or obesity which disrupt the optimal host immune response to infections. Current literature shows inconsistent evidence about the association of plasma 25(OH)D

objectivesThis study aimed to measure plasma 25(OH)D

methods167 patients were included in this analytical cross-sectional study, of which 81 were critical and 86 were non-critical hospitalized COVID-19 patients. Plasma levels of 25(OH)D

resultsPlasma 25(OH)D

conclusionThe current study found that critical COVID-19 patients had lower 25(OH)D

Indexed as

COVID-19Vitamin D DeficiencyCross-Sectional StudiesHumansInterleukin-10Interleukin-6Interleukin-8SARS-CoV-2Tumor Necrosis Factor-alphaVitamin DVitamin D-Binding Protein25-hydroxyvitamin DInterleukin-10Interleukin-6Interleukin-8Tumor Necrosis Factor-alphaVitamin DVitamin D-Binding Protein25(OH)D3COVID-19interleukin-10interleukin-6interleukin-8tumor necrosis factor alphavitamin D binding protein

Identifiers

PMID37111039
PMCPMC10142640
OpenAlexW4363674748

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.